We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Medic Bleep is a simple, secure and innovative patient-focused solution to communication challenges that healthcare professionals and the wider team in the UK National Health Service (NHS) face while going about their everyday work. It is saving each nurse & each junior doctor an estimated 48 minutes per shift. This coincides with the UK's Department of Health calling for a ban on pagers. If implemented across the NHS, it could free up the time to care for an estimated 11,000 nurses. To ensure data privacy and safety, the company allows communication to occur via the app. As a result of these safeguards and its user-friendly portal, the company's app has been downloaded 16,000 times by UK doctors and nurses. With the funds raised, the company will aim to solve looming technology gaps for over 30% of the NHS in the next 3 years and expand globally.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £814,600
A combination of gift-giving and online betting to create added exhilaration about upcoming sporting events. Giftmybet allows customers to buy gifts for others, which includes a personalised card that contains a betting slip. If it's a winner, they can redeem their cash prize at the Giftmybet website. The company is in discussion with a sportsbook provider, as well as receiving a £50,000 investment package from a web development firm.
days to go: Expired investment: £62,895
Intoware provide wearable, mobile and desktop technology to SME's and SAS clients. Intoware digitise the deskless workspace and therefore remove the need for paper checklists. Once a checklist is complete, Intoware is able to share the completed list with anyone it may concern.
days to go: Expired investment: £700,000
Magic is the only technology that can truly bridge online and traditional fashion retail. Our RFID tracking system can locate all product items in a real store in real-life and instantly detect their individual movement to 100% reliability.
days to go: Expired investment: £57,580
Raw Holo is an award-winning company, making organic raw chocolate bars with natural plant-based ingredients flavoured with coconut sugar. Its bars are wrapped in 100% recyclable, plastic-free packaging. The company has acquired national listings with Waitrose and Holland & Barrett in Feb 2019 and, sold 1 million bars till date. Its product is available in 1000+ stores in Ireland and Uk. The company will use the funds to launch into new major retailers, build the brand with creative marketing campaigns and grow the sales team.
days to go: Expired investment: £157,590
Victor Mobility have designed a mobility device to bring a disabled person into an able bodied environment. The mobility device will be modular so it will adapt to the users disability, it will go up and down a kerb, it will go inside and out so you don't have to buy two devices and it will enable the user to be at social height or eye height of 1.5m.
days to go: Expired investment: £716,150
Gively is an online marketplace where users can give and get secondhand items for free. The secondhand clothing market will double in value to £50 billion annually by 2023, and the company finds itself as a suitable contender in this domain. They aim to lower greenhouse gas emissions and minimise landfill sites through its portal. The company has reached over 5,000 users, 70% of which came from unpaid channels. Gively won an SME (Small and medium enterprises) grant worth £10,000 of television advertising and has received rave reviews from its users through the App Store, social media, and in person. They will use 50% of the investment for marketing purposes, 25% for technology up-gradation, and 25% for hiring human resources.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £105,207
SilkFred is a curated online marketplace for over 200 independent fashion brands. It’s a destination for customers seeking to differentiate their wardrobes. SilkFred cuts through the noise of online shopping and provides a central destination for female shoppers to find affordable pieces that their friends won’t have (and will love!). Having cultivated a cult social media status and attracted a growing number of loyal shoppers and brands, SilkFred is now ready to scale its business model rapidly. www.silkfred.com
days to go: Expired investment: £906,630
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go: Expired investment: £999,867
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go: Expired investment: £1,314,967
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph